Endothelin-1, a 21-residue peptide isolated from vascular endothelial
cells, has a broad spectrum of actions. To clarify the involvement of
endothelin-l in acute pancreatitis, we examined the effects of endothe
lin-l and its receptor antagonist BQ-123 on cerulein-induced pancreati
tis in rats. Rats were infused intravenously with heparin-saline (cont
rol), endothelin-l (100 pmol/kg/hr), cerulein (5 mu g/kg/hr), or cerul
ein plus endothelin-l for 3.5 hr. In another experiment, cerulein or c
erulein plus BQ-123 (3 mg/kg/hr) was infused. Infusion of cerulein cau
sed hyperamylasemia and pancreatic edema. Endothelin-l, when infused w
ith cerulein, decreased the extent of pancreatic edema with a signific
ant increase in the pancreatic dry- to wet-weight ratio. Histological
changes induced by cerulein were markedly attenuated when endothelin-l
was given with cerulein. In contrast, endothelin-receptor blockade wi
th BQ-123 further augmented pancreatic edema caused by cerulein. The e
xtent of inflammatory cell infiltration was greater when BQ-123 was gi
ven with cerulein. Endothelin-l or BQ-123 had no influence on hyperamy
lasemia. This study suggests that endothelin-l has protective effects
on experimental acute pancreatitis.